Heart function and fatigue in Friedreich's ataxia
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how the heart works during exercise and how that relates to fatigue in people with Friedreich's ataxia. You'll ride a stationary bike, and we'll measure your heart's output to understand fatigue better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a genetic diagnosis of Friedreich's ataxia
- You can safely ride a stationary bike (with a low sitting-posture score)
- You do not have severe depression (Beck score 19 or lower)
- You score at least 23 out of 30 on a memory and thinking test
- You have no other health problems that would make exercise unsafe (like heart, lung, or brain issues)
- You do not do intense endurance exercise more than 2 days a week
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses heart tests (including ultrasound and MRI) to better understand how Friedreich’s ataxia affects the heart. You might benefit by getting detailed heart evaluation and contributing to research that could guide future care.
This study looks at two brain chemicals (GABA and glutathione) in children and teens aged 8–15 with Friedreich's ataxia, a rare genetic condition affecting movement and coordination. The research aims to understand how these chemicals change in the brain and may help guide future treatments.
This study looks at “biomarkers” (measurable signs in the body, like test results from blood or other checks) in people with Friedreich’s ataxia. It may help researchers understand the disease better and track changes over time.
This study uses an EEG (a painless test that records your brain's electrical activity) to map the brain connections in people with Friedreich's ataxia. It aims to better understand how the condition affects the brain.
This study tests an investigational drug given as a daily injection to see if it can improve walking and balance in people with Friedreich's ataxia.
This trial tests a one-time gene therapy that delivers a corrected copy of the frataxin gene directly to the heart. It aims to improve or stabilize heart function in people with Friedreich's ataxia who have early or advanced heart involvement.
Hear when a new Friedreich's Ataxia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.